slides · global inventory
Diagram
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 23,622
Current window 16,111-16,140
Pages 788
Rows per page 30
Component
16,111-16,140 of 23,622
10
The slide uses a hub-and-spoke diagram to illustrate market positioning relative to competitors in four distinct categories.Dragonfly Energy | Investor Presentation Deck | 25 slides · Dragonfly Energy
Pitch deck Investor relations Beat · Product1 hit
21
The slide uses a process flow diagram on the left and a set of microscopy images on the right to demonstrate the 'integrated' nature of the battery layers.Dragonfly Energy | Investor Presentation Deck | 25 slides · Dragonfly Energy
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
10
The slide uses a hub-and-spoke visual to represent the company's ecosystem.Ecarx | Results Presentation Deck | 21 slides · Ecarx
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
09
Includes a process timeline and specific investment breakdown for capacity expansion.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Satisfaction1 hit
11
Includes a timeline at the bottom and specific financial/operational metrics.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
15
The slide uses a process flow for the utility side and a stakeholder/financing flow for the developer side.Eos Energy | Results Presentation Deck | 19 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Action1 hit
03
Uses a hub-and-spoke diagram to represent the company's strategic pillars.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Loop · Golden Circle1 hit
11
The diagram uses a hub-and-spoke model to show how various scientific disciplines feed into the central 'Drug Products' core.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
12
The slide uses a hub-and-spoke visual metaphor to explain the shared signaling mechanism of the γC receptor family.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
13
The slide uses a process diagram to show the transition from native cytokine sequences to a proprietary composite sequence, resulting in an engineered inhibitor.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
15
The slide uses a visual mechanism to show how different inhibitors interact with cell signaling pathways.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
22
The slide uses a circular process diagram to show the feedback loop of immune cells and cytokines attacking the hair follicle.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
26
Includes a timeline-style process diagram for the study phases.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
30
Includes a biological process diagram and a gene expression heatmap.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
31
The slide uses a biological pathway diagram and a bar chart to demonstrate efficacy.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
32
The slide uses a process-like diagram to show treatment approaches and highlights the specific mechanism of action (IL-15/IL-21 inhibition) as a superior strategy.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
33
The slide outlines a sequential clinical trial process.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
03
The slide uses a hub-and-spoke diagram to connect the company name to three core pillars: leadership, portfolio, and financials.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Introduction to Erasca and RAS/MAPK pathway1 hit
06
The diagram illustrates a biological signaling pathway with specific nodes highlighted as targets for the company's therapeutic approach.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Challenges in current cancer treatment and unmet needsLoop · Logic Chain1 hit
08
The slide uses a biological process diagram to map drug assets to specific protein targets.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Challenges in current cancer treatment and unmet needsLoop · Logic Chain1 hit
13
The slide combines a biological pathway diagram with a clinical trial summary table to demonstrate proof of concept.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Challenges in current cancer treatment and unmet needs1 hit
21
The diagram uses a flow-chart structure to categorize patient outcomes (off treatment vs on treatment) and further breaks down the 'on treatment' group into SDs and PRs with specific progression delay metrics.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
24
The slide uses a biological signaling pathway map to justify combination therapy strategy.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
25
The diagram shows the RAS/MAPK signaling pathway. The table provides a breakdown of patient populations for specific indications.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
31
The slide uses a process-oriented flow to demonstrate clinical validation milestones.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
36
The diagram shows the EGFR signaling pathway and the inhibitory effect of ERAS-801.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
45
The slide uses a matrix-like layout to compare drug candidates by development stage and company, with a callout box for competitive advantages.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
46
The slide uses a bullseye/concentric circle framework to communicate strategic prioritization of clinical trials.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
47
The slide uses a contrast-based layout to frame the subject as a winner in a difficult therapeutic space.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
54
The slide uses a comparative layout contrasting a list of competitor assets with the specific benefits of the company's own asset (ERAS-601).Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit